ARCHIVES

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

This article is from The Cancer Letter archive.

Vol. 36 No. 01 | January 15, 2010

Download PDF Visit The Full Archive

Related Articles

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

DeVita: “The War On Cancer Is Dead”

June 11, 2010